(Q54100725)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190732%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

Acute and chronic haemodynamic and renal effects of carvedilol in patients with cirrhosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190732%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190732%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

George Therapondos

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190732%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

4

P C Hayes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190732%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

A Helmy

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190732%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 March 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190732%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190732%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190732%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190732%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

479-484

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190732%20AND%20SRC:MED&resulttype=core&format=json

Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Meta-analysis of value of propranolol in prevention of variceal haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multic

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Oral isosorbide-5-mononitrate reduces the rebleeding rate during the course of injection sclerotherapy for esophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Review: pharmacotherapeutic agents in the treatment of portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Effects of Propranolol on Azygos Venous Blood Flow and Hepatic and Systemic Hemodynamics in Cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Short-term effects of propranolol on portal venous pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Effect of propranolol on urinary prostaglandin E2 excretion and renal interlobar arterial blood flow after furosemide administration in patients with hepatic cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide-5-mononitrate in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Pharmacodynamic profile of carvedilol

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980108-1

7 January 2021

10.1016/S0168-8278(99)80108-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10190732%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference